ContraFect Corp Performance

CFRXDelisted Stock  USD 1.18  0.08  6.35%   
The firm shows a Beta (market volatility) of 0.74, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, ContraFect Corp's returns are expected to increase less than the market. However, during the bear market, the loss of holding ContraFect Corp is expected to be smaller as well. ContraFect Corp right now shows a risk of 0.0%. Please confirm ContraFect Corp jensen alpha, skewness, as well as the relationship between the Skewness and day typical price , to decide if ContraFect Corp will be following its price patterns.

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ContraFect Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, ContraFect Corp is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
Begin Period Cash Flow4.7 M
  

ContraFect Corp Relative Risk vs. Return Landscape

If you would invest  118.00  in ContraFect Corp on August 29, 2024 and sell it today you would earn a total of  0.00  from holding ContraFect Corp or generate 0.0% return on investment over 90 days. ContraFect Corp is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than ContraFect, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  

ContraFect Corp Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for ContraFect Corp's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as ContraFect Corp, and traders can use it to determine the average amount a ContraFect Corp's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
CFRX
Based on monthly moving average ContraFect Corp is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ContraFect Corp by adding ContraFect Corp to a well-diversified portfolio.

ContraFect Corp Fundamentals Growth

ContraFect Stock prices reflect investors' perceptions of the future prospects and financial health of ContraFect Corp, and ContraFect Corp fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on ContraFect Stock performance.

About ContraFect Corp Performance

Evaluating ContraFect Corp's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if ContraFect Corp has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if ContraFect Corp has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
ContraFect Corporation, a clinical-stage biotechnology company, discovers and develops therapeutic protein and antibody products for the treatment of life-threatening and drug-resistant infectious diseases in the United States. ContraFect Corporation was incorporated in 2008 and is headquartered in Yonkers, New York. Contrafect operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 38 people.

Things to note about ContraFect Corp performance evaluation

Checking the ongoing alerts about ContraFect Corp for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for ContraFect Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
ContraFect Corp is not yet fully synchronised with the market data
ContraFect Corp may become a speculative penny stock
ContraFect Corp has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (24.14 M) with loss before overhead, payroll, taxes, and interest of (1.61 M).
ContraFect Corp currently holds about 27.3 M in cash with (35.59 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.69.
Evaluating ContraFect Corp's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate ContraFect Corp's stock performance include:
  • Analyzing ContraFect Corp's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether ContraFect Corp's stock is overvalued or undervalued compared to its peers.
  • Examining ContraFect Corp's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating ContraFect Corp's management team can have a significant impact on its success or failure. Reviewing the track record and experience of ContraFect Corp's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of ContraFect Corp's stock. These opinions can provide insight into ContraFect Corp's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating ContraFect Corp's stock performance is not an exact science, and many factors can impact ContraFect Corp's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Other Consideration for investing in ContraFect Stock

If you are still planning to invest in ContraFect Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ContraFect Corp's history and understand the potential risks before investing.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Commodity Directory
Find actively traded commodities issued by global exchanges
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Equity Valuation
Check real value of public entities based on technical and fundamental data
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges